Clinical characteristics and treatment of pars planitis: an adalimumab experience

---

Copy For Citation

Özdemir H. B., Ozdal P. C.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, vol.260, no.2, pp.561-569, 2022 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 260 Issue: 2
• Publication Date: 2022
• Doi Number: 10.1007/s00417-021-05398-4
• Journal Name: GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
• Page Numbers: pp.561-569
• Keywords: Pars planitis, Intermediate uveitis, Immunosuppressive treatment, Anti-tumour necrosis factor treatment, Adalimumab, NONINFECTIOUS UVEITIS, THERAPY, RETINOSCHISIS, MULTICENTER
• Gazi University Affiliated: Yes

Abstract

Purpose This study aims to investigate the clinical and demographic characteristics, treatment outcomes and complications of patients with pars planitis.